2023年6月最新SCI影响因子数据已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Frontiers in Immunology FRONT IMMUNOL （此期刊被最新的JCR期刊SCIE收录） LetPub评分 8.0
98人评分
我要评分
声誉 8.1 影响力 7.4 速度 8.8 | |||||||||||||||||||||
| 期刊ISSN | 1664-3224 | 微信扫码收藏此期刊 | ||||||||||||||||||||
| 2022-2023最新影响因子 （数据来源于搜索引擎） | 7.3 点击查看影响因子趋势图 | |||||||||||||||||||||
| 实时影响因子 | 截止2023年9月27日：3.504 | |||||||||||||||||||||
| 2022-2023自引率 | 11.00%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年影响因子 | 8 | |||||||||||||||||||||
| h-index | 84 | |||||||||||||||||||||
| CiteScore |
| |||||||||||||||||||||
| 期刊简介 | Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology. Field Chief Editor Luigi Daniele Notarangelo is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. Frontiers in Immunology is the official Journal of the International Union of Immunological Societies (IUIS). Encompassing the entire field of Immunology, this journal welcomes papers that investigate basic mechanisms of immune system development and function, with a particular emphasis given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis. | |||||||||||||||||||||
| 期刊官方网站 | http://journal.frontiersin.org/journal/immunology | |||||||||||||||||||||
| 期刊投稿网址 | http://www.frontiersin.org/submission/submissioninfo.aspx | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Frontiers in Immunology的语言要求，还能让Frontiers in Immunology编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Frontiers in Immunology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||
OA期刊相关信息 | 文章处理费：需要（ USD2950; ） 文章处理费豁免：查看说明 其他费用：没有 期刊主题关键词：immunology、adaptive immunity、innate immunity、clinical immunology、molecular immunology 相关链接：Aims & ScopeAuthor InstructionsEditorial BoardBlind peer review | |||||||||||||||||||||
| 通讯方式 | AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, SWITZERLAND, CH-1015 | |||||||||||||||||||||
| 出版商 | Frontiers Media S.A. | |||||||||||||||||||||
| 涉及的研究方向 | IMMUNOLOGY- | |||||||||||||||||||||
| 出版国家或地区 | SWITZERLAND | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | ||||||||||||||||||||||
| 出版年份 | 0 | |||||||||||||||||||||
| 年文章数 | 7792点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 99.46% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 72.57% | |||||||||||||||||||||
| WOS期刊SCI分区 （ 2022-2023年最新版） | WOS分区等级：1区
| |||||||||||||||||||||
| 中科院《国际期刊预警 名单（试行）》名单 | 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2021年01月发布的2020版：不在预警名单中 | |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2022年12月最新升级版） | 点击查看中科院SCI期刊分区趋势图
| |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月基础版） |
| |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月升级版） |
| |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1664-3224%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 14 Weeks | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Frontiers in Immunology顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Serplulimab plus chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: A cost-effectiveness analysis Author: Zhu, Youwen; Liu, Kun; Qin, Qun; Zhu, Hong Journal: FRONTIERS IN IMMUNOLOGY. 2023; Vol. 13, Issue , pp. -. DOI: 10.3389/fimmu.2022.1044678 PubMed DOI |
| 2. | Using two-step cluster analysis to classify inpatients with primary biliary cholangitis based on autoantibodies: A real-world retrospective study of 537 patients in China Author: Zhao, Dan-Tong; Yan, Hui-Ping; Liao, Hui-Yu; Liu, Yan-Min; Han, Ying; Zhang, Hai-Ping; Zhang, Wei-Ming; Huang, Chun-Yang; Liu, Xiu-Hong; Lou, Jin-Li; Zhao, Yan Journal: FRONTIERS IN IMMUNOLOGY. 2023; Vol. 13, Issue , pp. -. DOI: 10.3389/fimmu.2022.1098076 PubMed DOI |
| 3. | The altered metabolites contributed by dysbiosis of gut microbiota are associated with microbial translocation and immune activation during HIV infection Author: Zhang, Yu; Xie, Zhiman; Zhou, Jie; Li, Yanjun; Ning, Chuanyi; Su, Qisi; Ye, Li; Ai, Sufang; Lai, Jingzhen; Pan, Peijiang; Liu, Ningmei; Liao, Yanyan; Su, Qijian; Li, Zhuoxin; Liang, Hao; Cui, Ping; Huang, Jiegang Journal: FRONTIERS IN IMMUNOLOGY. 2023; Vol. 13, Issue , pp. -. DOI: 10.3389/fimmu.2022.1020822 PubMed DOI |
| 4. | Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection Author: Zhang, Lu; Jiang, Tingting; Yang, Ying; Deng, Wen; Lu, Huihui; Wang, Shiyu; Liu, Ruyu; Chang, Min; Wu, Shuling; Gao, Yuanjiao; Hao, Hongxiao; Shen, Ge; Xu, Mengjiao; Chen, Xiaoxue; Hu, Leiping; Yang, Liu; Bi, Xiaoyue; Lin, Yanjie; Lu, Yao; Jiang, Yuyong; Li, Minghui; Xie, Yao Journal: FRONTIERS IN IMMUNOLOGY. 2023; Vol. 13, Issue , pp. -. DOI: 10.3389/fimmu.2022.1112234 PubMed DOI |
| 5. | Depressive symptoms predict longitudinal changes of chronic inflammation at the transition to adulthood Author: Zhai, Shuang; Qu, Yang; Zhang, Dan; Li, Tingting; Xie, Yang; Wu, Xiaoyan; Zou, Liwei; Yang, Yajuan; Tao, Fangbiao; Tao, Shuman Journal: FRONTIERS IN IMMUNOLOGY. 2023; Vol. 13, Issue , pp. -. DOI: 10.3389/fimmu.2022.1036739 PubMed DOI |
| 6. | Granulocytic myeloid-derived suppressor cells increase infection risk via the IDO/IL-10 pathway in patients with hepatitis B virus-related liver failure Author: Yu, Xueping; Sun, Jian; Yang, Feifei; Mao, Richeng; Shen, Zhiqing; Ren, Lan; Yuan, Songhua; He, Qian; Zhang, Linxia; Yang, Yu; Ding, Xiangqing; He, Yongquan; Zhu, Haoxiang; Shen, Zhongliang; Zhu, Mengqi; Qiu, Chao; Su, Zhijun; Zhang, Jiming Journal: FRONTIERS IN IMMUNOLOGY. 2023; Vol. 13, Issue , pp. -. DOI: 10.3389/fimmu.2022.966514 PubMed DOI |
| 7. | Combination of transcriptional biomarkers and clinical parameters for early prediction of sepsis indued acute respiratory distress syndrome Author: Yao, Ren-Qi; Shen, Zong; Ma, Qi-Min; Ling, Ping; Wei, Chen-Ru; Zheng, Li-Yu; Duan, Yu; Li, Wei; Zhu, Feng; Sun, Yu; Wu, Guo-Sheng Journal: FRONTIERS IN IMMUNOLOGY. 2023; Vol. 13, Issue , pp. -. DOI: 10.3389/fimmu.2022.1084568 PubMed DOI |
| 8. | m6A eraser FTO modulates autophagy by targeting SQSTM1/P62 in the prevention of canagliflozin against renal fibrosis Author: Yang, Youjing; Li, Qianmin; Ling, Yi; Leng, Linxin; Ma, Yu; Xue, Lian; Lu, Guoyuan; Ding, Yue; Li, Jianzhong; Tao, Shasha Journal: FRONTIERS IN IMMUNOLOGY. 2023; Vol. 13, Issue , pp. -. DOI: 10.3389/fimmu.2022.1094556 PubMed DOI |
| 9. | Apoptosis in megakaryocytes: Safeguard and threat for thrombopoiesis Author: Yang, Shuo; Wang, Long; Wu, Yuesong; Wu, Anguo; Huang, Feihong; Tang, Xiaoqin; Kantawong, Fahsai; Anuchapreeda, Songyot; Qin, Dalian; Mei, Qibing; Chen, Jianping; Huang, Xinwu; Zhang, Chunxiang; Wu, Jianming Journal: FRONTIERS IN IMMUNOLOGY. 2023; Vol. 13, Issue , pp. -. DOI: 10.3389/fimmu.2022.1025945 PubMed DOI |
| 10. | Functional status and spatial interaction of T cell subsets driven by specific tumor microenvironment correlate with recurrence of non-small cell lung cancer Author: Yang, Liying; Zhang, Wei; Sun, Jujie; Yang, Guanqun; Cai, Siqi; Sun, Fenghao; Xing, Ligang; Sun, Xiaorong Journal: FRONTIERS IN IMMUNOLOGY. 2023; Vol. 13, Issue , pp. -. DOI: 10.3389/fimmu.2022.1022638 PubMed DOI |
|
|
  | |
|
以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分： | |
同领域作者分享投稿经验：共56条 （包含回复） |
我来分享 |
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2023 中国: LetPub上海分公司 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960
增值电信业务经营许可证：沪B2-20211595
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦2103室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451
安全保密
